EUVIMEDEUVIMED entdecken
Crossref

Suppression of Salmonella Effectors with CRISPRi Controls the Immune Response to Bacterial Therapies

Chinmay Deshpande, Shradha Khanduja, Stephen N Rondthaler, Lauren B Andrews iD, Neil S Forbes iD

ACS Synthetic Biology · 17.07.2026 · 15 (7) · 2912-2924

DOI: 10.1021/acssynbio.6c00041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 30.06.2026. Verfasst von Chinmay Deshpande und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States. Hauptthemen laut MEDLINE: Bacterial Proteins, Salmonella typhimurium, Salmonella. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Cancer Institute, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial ProteinsSalmonella typhimuriumSalmonellaHumansMacrophagesSTAT3 Transcription FactorAnimalsProto-Oncogene Proteins c-aktInterleukin-10PhosphorylationCell Line, TumorApoptosisMiceTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

CRISPRiSalmonellacancer therapyeffector proteinsimmune modulationimmunosuppression

Substanzen

Bacterial ProteinsSTAT3 Transcription FactorSopB protein, SalmonellaProto-Oncogene Proteins c-aktInterleukin-10Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
  • Molecular and Cell Biology Program, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
  • Institute for Applied Life Science, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
  • Biotechnology Training Program, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
  • Department of Microbiology, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.

ORCID-Profile: Lauren B Andrews, Neil S Forbes

Förderung

  • National Cancer Institute
  • U.S. Department of Defense

Zitieren

APA

Deshpande, C., Khanduja, S., Rondthaler, S. N., Andrews, L. B., & Forbes, N. S. (2026). Suppression of Salmonella Effectors with CRISPRi Controls the Immune Response to Bacterial Therapies. ACS Synthetic Biology, 15(7), 2912-2924. https://doi.org/10.1021/acssynbio.6c00041

Vancouver

Deshpande C, Khanduja S, Rondthaler SN, Andrews LB, Forbes NS. Suppression of Salmonella Effectors with CRISPRi Controls the Immune Response to Bacterial Therapies. ACS Synthetic Biology. 2026;15(7):2912-2924. doi:10.1021/acssynbio.6c00041

BibTeX
@article{Deshpande2026,
  author = {Deshpande, Chinmay and Khanduja, Shradha and Rondthaler, Stephen N and Andrews, Lauren B and Forbes, Neil S},
  title = {Suppression of Salmonella Effectors with CRISPRi Controls the Immune Response to Bacterial Therapies},
  journal = {ACS Synthetic Biology},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {2912--2924},
  doi = {10.1021/acssynbio.6c00041}
}
Kostenlos starten →